Athena Athena

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of AM20061770 on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
395
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 15MG BASE
  • TABLET;ORAL - EQ 30MG BASE
  • TABLET;ORAL - EQ 45MG BASE
  • TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - 850MG;EQ 15MG BASE
  • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE
  • TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
9101660
Y
2027-01-22
21842
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8173663
2025-03-15
U-1338
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING A COMPOUND SUCH AS ALOGLIPTIN
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7959946
Y
2026-07-31
22024
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8173663
2025-03-15
U-1338
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING A COMPOUND SUCH AS ALOGLIPTIN
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8288539
Y
2025-03-15
22426
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7785627
Y
2026-07-31
22024
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8637079
Y
2029-06-04
22426
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
9101660
Y
2027-01-22
21842
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8071130
Y
2028-06-08
21925
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7785627
Y
2026-07-31
22024
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7807689
Y
Y
2028-06-27
U-1337
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8637079
Y
2029-06-04
22426
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7700128
Y
2027-01-30
21925
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8173663
2025-03-15
U-1338
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING A COMPOUND SUCH AS ALOGLIPTIN
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7807689
Y
Y
2028-06-27
U-1337
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8071130
Y
2028-06-08
21925
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8288539
Y
2025-03-15
22426
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8288539
Y
2025-03-15
22426
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7959946
Y
2026-07-31
22024
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8637079
Y
2029-06-04
22426
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8173663
2025-03-15
U-1338
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING A COMPOUND SUCH AS ALOGLIPTIN
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8288539
Y
2025-03-15
22426
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8637079
Y
2029-06-04
22426
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8173663
2025-03-15
U-1338
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING A COMPOUND SUCH AS ALOGLIPTIN
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7807689
Y
Y
2028-06-27
U-1337
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7807689
Y
Y
2028-06-27
U-1337
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
9320714
Y
2029-02-03
21842
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7807689
Y
Y
2028-06-27
U-1337
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8288539
Y
2025-03-15
22426
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8637079
Y
2029-06-04
22426
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8173663
2025-03-15
U-1338
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING A COMPOUND SUCH AS ALOGLIPTIN
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8637079
Y
2029-06-04
22426
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7700128
Y
2027-01-30
21925
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
8288539
Y
2025-03-15
22426
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
7807689
Y
Y
2028-06-27
U-1337
22426
METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Japan
Digital Content Digital Content
URL Supplier Web Content
9320714
Y
2029-02-03
21842
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY